BiotechTube
Home/Yarrow Bioscience/Matthew Zola
MZ

Matthew Zola

Author of Press Release

Yarrow Bioscience

Therapeutic Areas

Autoimmune DiseasesEndocrinology

Yarrow Bioscience Pipeline

DrugIndicationPhase
YB-101 (GS-098)Graves' DiseasePhase 1b/2b

Leadership Team at Yarrow Bioscience

RF
Rebecca Frey
President and Chief Executive Officer
DD
David Domzalski
President and Chief Executive Officer of VYNE Therapeutics (pre-merger)
View full Yarrow Bioscience profile